nach oben

Tumor Biology

Erschienen in:

01.02.2014 | Research Article

Association of XRCC1 genetic polymorphism (Arg399Gln) with laryngeal cancer: a meta-analysis based on 4,031 subjects

verfasst von: W. Chen, Z. Y. Wang, F. L. Xu, K. M. Wu, Y. Zhang, L. Xu, Q. P. Wang

Erschienen in: Tumor Biology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Several case–control studies on the relation between XRCC1 gene Arg399Gln polymorphism and laryngeal cancer do not have similar conclusions. To further evaluate the relation between the XRCC1 gene Arg399Gln polymorphism and laryngeal cancer, we selected seven case–control studies related to the XRCC1 gene Arg399Gln polymorphism and laryngeal cancer by searching MEDLINE, EMBase, Chinese Biomedical Literature Database, Chinese CNKI, and Wanfang database. We utilized Q test and I ² test to test the heterogeneity between each study. The fixed effects model was utilized to calculate the odds ratio (OR) and 95 % confidence interval. The present study included 1,654 patients with laryngeal cancer and 2,377 cancer-free control subjects. By meta-analysis, we did not find any association of XRCC1 gene Arg399Gln polymorphism with laryngeal cancer (OR = 1.13, 95 % CI 0.81–1.58, P = 0.47). Therefore, we concluded that XRCC1 gene Arg399Gln polymorphism was not associated with laryngeal cancer.

Tahtali A, Hey C, Geissler C, Filman N, et al. HPV status and overall survival of patients with oropharyngeal squamous cell carcinoma—a retrospective study of a German head and neck cancer center. Anticancer Res. 2013;33(8):3481–5.PubMed

Hakenewerth AM, Millikan RC, Rusyn I, et al. Joint effects of alcohol consumption and polymorphisms in alcohol and oxidative stress metabolism genes on risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev. 2011;20(11):2438–49.PubMedCentralPubMedCrossRef

Li X, Hu Z, Qu X, et al. Putative EPHX1 enzyme activity is related with risk of lung and upper aerodigestive tract cancers: a comprehensive meta-analysis. PLoS One. 2011;6(3):e14749.PubMedCentralPubMedCrossRef

Canova C, Hashibe M, Simonato L, et al. Genetic associations of 115 polymorphisms with cancers of the upper aerodigestive tract across 10 European countries: the ARCAGE project. Cancer Res. 2009;69(7):2956–65.PubMedCrossRef

Russo A, Francelin PR, Galbiatti AL, et al. Association between GSTP1, GSTM1 and GSTT1 polymorphisms involved in xenobiotic metabolism and head and neck cancer development. Mol Biol Rep. 2013;40(7):4181–8.PubMedCrossRef

Wang J, Gao J, Li Y, et al. Functional polymorphisms in FAS and FASL contribute to risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population. Gene. 2013;524(2):193–6.PubMedCrossRef

Wang J, Jin X, Wang H, et al. The -308G/A polymorphism of the tumor necrosis factor-alpha gene is associated with the risk of upper aerodigestive tract cancer: a meta-analysis. Tohoku J Exp Med. 2013;229(4):245–54.PubMedCrossRef

Wang JR, Gramling SJ, Goldstein DP, et al. Association of two BRM promoter polymorphisms with head and neck squamous cell carcinoma risk. Carcinogenesis. 2013;34(5):1012–7.PubMedCrossRef

Mahjabeen I, Baig RM, Masood N, et al. Genetic variations in XRCC1 gene in sporadic head and neck cancer (HNC) patients. Pathol Oncol Res. 2013;19(2):183–8.PubMedCrossRef

10.

Yang Y, Tian H, Zhang ZJ. Association of the XRCC1 and hOGG1 polymorphisms with the risk of laryngeal carcinoma. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008;25(2):211–3.PubMed

11.

Krupa R, Kasznicki J, Gajęcka M, et al. Polymorphisms of the DNA repair genes XRCC1 and ERCC4 are not associated with smoking- and drinking-dependent larynx cancer in a Polish population. Exp Oncol. 2011;33(1):55–6.PubMed

12.

Matullo G, Dunning AM, Guarrera S, et al. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis. 2006;27(5):997–1007.PubMedCrossRef

13.

Gajecka M, Rydzanicz M, Jaskula-Sztul R, et al. Reduced DNA repair capacity in laryngeal cancer subjects. A comparison of phenotypic and genotypic results. Adv Otorhinolaryngol. 2005;62:25–37.PubMed

14.

Varzim G, Monteiro E, Silva RA, et al. CYP1A1 and XRCC1 gene polymorphisms in SCC of the larynx. Eur J Cancer Prev. 2003;12(6):495–9.PubMedCrossRef

15.

Bogela A, Yalikun Y, Ayihen Q. Study on polymorphism and genetic susceptibility of laryngeal of Arg399Gln gene in different ethnic group in Xinjiang. J Xinjiang Med Univ. 2011;34(11):1247–50.

16.

Tian H, Yang Y, He S, et al. Association of the XRCC1 and XPD polymorphism with risk of laryngeal carcinoma. Chin J Rehabil. 2010;25:9–13.

17.

Shen MR, Zdzienicka MZ, Mohrenweiser H, Thompson LH, Thelen MP. Mutations in hamster single-strand break repair gene XRCC1 causing defective DNA repair. Nucleic Acids Res. 1998;26(4):1032–7.

18.

Bork P, Hofmann K, Bucher P, et al. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 1997;11(1):68–76.PubMed

19.

Masson M, Niedergang C, Schreiber V, et al. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol. 1998;18(6):3563–71.PubMedCentralPubMed

20.

Ramachandran S, Ramadas K, Hariharan R, et al. Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncol. 2005;42:350–62.PubMedCrossRef

21.

Au WW, Salama SA, Sierra-Torres CH. Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Perspect. 2003;111:1843–50.PubMedCentralPubMedCrossRef

Titel: Association of XRCC1 genetic polymorphism (Arg399Gln) with laryngeal cancer: a meta-analysis based on 4,031 subjects
verfasst von: W. Chen
Z. Y. Wang
F. L. Xu
K. M. Wu
Y. Zhang
L. Xu
Q. P. Wang
Publikationsdatum: 01.02.2014
Verlag: Springer Netherlands
Erschienen in: Tumor Biology / Ausgabe 2/2014
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-013-1225-x

Springer Medizin

Association of XRCC1 genetic polymorphism (Arg399Gln) with laryngeal cancer: a meta-analysis based on 4,031 subjects

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2014

TP53 immunohistochemical expression is associated with the poor outcome for hepatocellular carcinoma: evidence from a meta-analysis

Inhibition of gastric cancer cell growth and invasion through siRNA-mediated knockdown of guanine nucleotide exchange factor Vav3

The tumor suppressor LKB1 antagonizes WNT signaling pathway through modulating GSK3β activity in cell growth of esophageal carcinoma

Associations between vascular endothelial growth factor polymorphisms and prostate cancer risk: a meta-analysis

Functional MUC4 suppress epithelial–mesenchymal transition in lung adenocarcinoma metastasis

Biological significance of promoter hypermethylation of p14/ARF gene: Relationships to p53 mutational status in Tunisian population with colorectal carcinoma

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie